tiprankstipranks
Cordlife Group Limited (SG:P8A)
SGX:P8A

Cordlife Group (P8A) Share Price & Analysis

0 Followers

P8A Stock Chart & Stats

Day’s RangeS$0 - S$0
52-Week RangeS$0.16 - S$0.57
Previous CloseS$0.27
Volume75.00K
Average Volume (3M)400.25K
Market Cap
S$74.04M
Enterprise ValueS$11.35M
Total Cash (Recent Filing)S$65.17M
Total Debt (Recent Filing)S$2.22M
Price to Earnings (P/E)18.3
Beta0.63
May 10, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding256,307,744
10 Day Avg. Volume32,980
30 Day Avg. Volume400,248
Standard Deviation0.08
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.01%0.00%0.06%97.93%
0.06% Other Institutional Investors
97.93% Public Companies and
Individual Investors

P8A FAQ

What was Cordlife Group Limited’s price range in the past 12 months?
Cordlife Group Limited lowest share price was S$0.15 and its highest was S$0.57 in the past 12 months.
    What is Cordlife Group Limited’s market cap?
    Currently, no data Available
    When is Cordlife Group Limited’s upcoming earnings report date?
    Cordlife Group Limited’s upcoming earnings report date is May 10, 2024 which is in 68 days.
      How were Cordlife Group Limited’s earnings last quarter?
      Cordlife Group Limited released its earnings results on Feb 29, 2024. The company reported S$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.006.
        Is Cordlife Group Limited overvalued?
        According to Wall Street analysts Cordlife Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cordlife Group Limited pay dividends?
          Cordlife Group Limited pays a Notavailable dividend of <S$0.01 which represents an annual dividend yield of N/A. See more information on Cordlife Group Limited dividends here
            What is Cordlife Group Limited’s EPS estimate?
            Cordlife Group Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cordlife Group Limited have?
            Cordlife Group Limited has 267,525,360 shares outstanding.
              What happened to Cordlife Group Limited’s price movement after its last earnings report?
              Cordlife Group Limited reported an EPS of S$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.333%.
                Which hedge fund is a major shareholder of Cordlife Group Limited?
                Currently, no hedge funds are holding shares in SG:P8A
                ---

                Cordlife Group Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -17.85%
                12-Months-Change

                Fundamentals

                Return on Equity
                2.73%
                Trailing 12-Months
                Asset Growth
                2.01%
                Trailing 12-Months

                Company Description

                Cordlife Group Limited

                Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, and cord lining and tissue services, which collects, processes and stores in laboratories. The Diagnostics segment consists of Metascreen, which is anon-invasive metabolic screening test designed for newborn babies, non-invasive prenatal testing and eyescreen, and a paediatric vision-screening services. The company was founded on May 2, 2001 and is headquartered in Singapore.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                BIMI International Medical
                BioNano Genomics
                Cocrystal Pharma
                Verastem
                Cordlife Group
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis